• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Cerner, Icon partner to streamline late-phase research studies

Cerner, Icon partner to streamline late-phase research studies

January 14, 2013
CenterWatch Staff

Cerner, a global innovator in electronic health record (EHR) and research technology, and global CRO Icon have formed an agreement to provide pharmaceutical and device sponsors with late-phase research technology to streamline the collection of information related to the safety, effectiveness and value of their medical products.

As healthcare models continue to evolve, late-phase research studies play a key role by providing additional assurance of product safety, comparative effectiveness, awareness of potential expanded indications for use and an understanding of the impact on patient outcomes and quality of life.

Icon selected Cerner’s Discovere Late Phase solution as its system of choice for its late-phase projects after an extensive evaluation process.

“Discovere Late Phase is a highly scalable and flexible platform that is able to support late phase study management and provides sponsors with the ability to capture research data across multiple research sites,” said Elizabeth Thiele, president of late phase and outcomes research division for Icon. “Cerner's web-based research solution was built to accommodate the diversity of late-phase studies, an improvement over other technologies that may have been retro-fitted from cumbersome legacy systems.”

Discovere Late Phasereduces the time required to start late-phase studies, provides sites with an easy-to-use system for compiling data and expedites the reporting of valuable data back to sponsors and regulators. The solution can also integrate into the EHR workflow, giving site researchers the ability to electronically transcribe study-relevant data from the EHR directly into the online study forms. Additionally, the system supports the capture of participant surveys and patient-reported outcomes through its integrated electronic patient-reported outcomes (ePRO) capabilities.

“Combining Icon’s expertise in study management with Cerner’s late-phase technology will greatly benefit study sponsors,” said Mark Hoffman, Ph.D., vice president of Cerner Research. “We look forward to ongoing collaboration with Icon focused on improving research and minimizing barriers to research participation.”

Upcoming Events

  • 12Apr

    The Participant Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing